Sequoia-Backed MedGenome Acquires Prognosis Labs

Sequoia-Backed MedGenome Acquires Prognosis Labs

SUMMARY

The acquisition would help MedGenome strengthen its diagnostic foothold in north India and cater to the needs of a larger population base

Founded in 2013, Prognosis is a NABL accredited, ICMR approved and AERB Certified pathology lab with a test catalgoue of over 700 tests

Last year, MedGenome raised $50 Mn in a strategic funding round led by life sciences investor Novo Holdings.

Sequoia Capital-backed genomics-driven diagnostics and research startup MedGenome has acquired Prognosis Laboratories to expand its geographical presence. 

The acquisition would help MedGenome strengthen its diagnostic foothold in north India and cater to the needs of a larger population base. 

The financial details of the deal were not disclosed.

Established in 2013, Prognosis Labs is led by Dr. Smita Sadwani, Dr. Deepak  Sadwani and Mr. Mayank Madan. It is  a NABL accredited, ICMR approved and AERB Certified pathology lab. It claims to have a test catalgoue of 700+ tests spread across pathology, radiology with a  specialisation in molecular diagnostics, histopathology, immunohistochemistry,  immunology, biochemistry, microbiology and serology using the latest technology. 

Commenting on the acquisition, Deepak Sadwani said that the deal will accelerate the next phase of growth and expansion of Prognosis’ overall business.

Founded by Mahesh Pratapneni and Sam Santhosh in 2013, MedGenome is a CAP accredited genetic testing laboratory that offers over 1,300 genetics tests across various disease categories. 

Besides Sequoia, MedGenome is backed by the likes of LeapFrog Investments,  Novo Holdings, Sofina, HDFC, Emerge Ventures, Zodius Capital and International Finance  Corporation. 

Last year, the Bengaluru based startup raised $50 Mn in a strategic funding round led by life sciences investor Novo Holdings.

The startup then said it would use the proceeds to broaden its product portfolio, improve the reach of its diagnostic services across reproductive and oncology domains, and invest in enhancing bioinformatics and software-as-a-service (SaaS) offerings. 

Earlier, it raised $55 Mn in 2020 in a funding round led by LeapFrog Investments. Overall, MedGenome has raised total funding of over $180 Mn to date.

The startup competes with the likes of MapMyGenome and Positive Bioscience in India.

The Indian diagnostics market is estimated to be worth $11 Bn currently. With an increasing population, rising economy and new breakthroughs in medical technology, this market size is expected to keep rising. 

According to an Inc42 report, the country’s ehealth market is expected to reach a size of $21 Bn by 2025.

You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
Unlock 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
Unlock 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

Sequoia-Backed MedGenome Acquires Prognosis Labs-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

Sequoia-Backed MedGenome Acquires Prognosis Labs-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

Sequoia-Backed MedGenome Acquires Prognosis Labs-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

Sequoia-Backed MedGenome Acquires Prognosis Labs-Inc42 Media
Sequoia-Backed MedGenome Acquires Prognosis Labs-Inc42 Media
You’re in Good company